Please ensure Javascript is enabled for purposes of website accessibility
Jim Halley

Jim Halley


Recent articles


2 Marijuana Stocks You Can Buy and Hold for the Next Decade

Lower your investing risk by buying stock in cannabis companies that are already turning a profit.


Why Canopy Growth's Shares Jumped 22.4% This Week

Canopy has had a rough year, but its shares saw a brief jump this week.


Why Liquidia Shares Rose 18.4% on Monday

Optimism by the company regarding a patent ruling is encouraging investors.


Why Invitae Corporation Stock Jumped 23% This Week

The stock had a big climb after its second-quarter report.


2 Cannabis Stocks You Can Buy and Hold for the Next Decade

These two companies are already profitable, and at their current share prices, they're solid long-term buys.

DNA genetic sequencing biotech

Why Shares of Co-Diagnostics Stock Fell 10% on Tuesday

The stock dropped two days before reporting second-quarter earnings.


Why Shares of Abiomed Rose 18.4% in July

The company's stock rose steadily throughout the month.


Why Shares of Align Technology Rose 18.7% in July

Investors shrugged off a so-so second-quarter report.


Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash

Consumers turn to these two retailers in recessions to save money.


Why Twist Bioscience's Shares Rose 25.1% in July

Two bits of positive news spurred the stock's rise.


Why Shares of MannKind Corporation Climbed 10.4% on Monday

The company is coming off an FDA approval for its second marketed drug.

doctor scientist microscope gloves mask

2 Biotech Stocks That Could Help Make You a Fortune

These companies have seen triple-digit revenue growth in recent years.


Why Virax Biolabs Stock Plummeted 74% On Friday

The stock had a wild trading day with an initial upswing, followed by a strong downtrend.


Why Shares of Bausch Health Companies Dropped 54.4% This Week

A patent-court loss sent investors scurrying to the exits.


Why Legend Biotech's Shares Jumped 11.8% on Wednesday

Investors, on second glance, might think the company's stock offering is a good idea.

Why Shares of Agenus Inc. Rose 10.1% on Tuesday

The company has a promising colon cancer therapy.


Why Shares of Verve Therapeutics Shot Up 44.9% This Week

The gene-editing company is getting an infusion of cash.


2 Biotech Stocks to Help Recession-Proof Your Portfolio

These companies' shares have outpaced the market and other biotech stocks this year.


Why GlaxoSmithKline Stock Jumped 25% on Thursday

Investors may be warming to the company's spin-off of its consumer healthcare division.


Why Shares of Clene Jumped 11.8% on Monday

The company's lead therapy has shown progress against ALS in preliminary trials.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.